EU Daily 18.9.2026

brief · 2026-09-18 · procurement · aerospace-defence · industrials · 1-4 weeks

§01 · Macro snapshot

§02 · Themes of the week

The Public Procurement Act — rewriting how EU spending is bought

On 8 September the Commission published its Public Procurement Act proposal (ip_26_1817) alongside factsheet fs_26_1821. Vice-President Séjourné and Commissioner Zaharieva presented it the next day (speech_26_1826). The proposal replaces the 2014 directives that govern roughly 14% of EU GDP in public spending — the text sitting under every ministry, hospital, city and defence buyer in the union. The rewrite pushes strategic criteria: security-of-supply, EU value-add, and lifecycle cost rather than lowest bid. Two days after the presentation, the EU awarded its sovereign satellite constellation to a Belgian startup over Airbus — an early signal that "strategic autonomy" is already shaping award decisions. Any European supplier that has been pricing on a lowest-bid regime — cloud vendors, primes, pharma tender bidders — should assume the goalposts move over the next 18-24 months.

Counter-thesis: the 2014 directives took nearly a decade to move through national transposition. If the same happens here, practical procurement flow through 2027 still runs on the old regime, and today's strategic-autonomy signal is a political banner rather than a live award pattern.

This would be wrong if national governments — particularly Germany, Poland, and France — start awarding under strategic-clause pilot programmes before the new act clears co-decision. Watch defence, satellite, and health-tech contracts in Q4 for wording that anticipates the proposal rather than citing the 2014 directive.

Sources: European Commission, TechTimes.

Poland as the forward operating base

Tusk travelled to Kyiv this week warning openly of Russian strikes on Ukraine's allies. France 24's headline reports Trump claiming "major progress" toward a US military base in Poland. RTX-Pratt & Whitney committed $25M to expanding engine parts capacity in Poland. Italy separately committed warships to protect shipping through Bab al-Mandeb — a second point on the map where European navies are doing sovereign posture, not just presence. Poland drew 1,165 press mentions in the window against 316 for Italy and 315 for Spain — roughly 3.7× either. Allianz separately said it has no material exposure to the Radiant World loss event, which matters mostly in what it does not say: reinsurance capacity is not yet being consumed by eastern-flank claims.

Counter-thesis: much of the Poland volume is US election cycle and Tusk personality. The industrial commitment stalls if the base talks slide past their unofficial autumn deadline or if the next Polish budget prints a defence-spending cut.

This would be wrong if the next Polish budget prints a defence spending cut, or the US base commitment fails to move to a signed status-of-forces text before year-end.

Sources: Al Jazeera, France 24, The Guardian, TASS.

The European large-cap tape says AI capex is rolling, luxury is broken

ASML fell 6.77% on the week and 13.88% on the month. The company's EUV order book is reported sold out through 2027 — a fully committed capital-equipment franchise trading through a fast fade. Long-dated call positioning stays bullish while the tape sells the front end. Airbus lost 8.39% on the month; over the same window the EU awarded its sovereign satellite constellation to a Belgian startup rather than the incumbent prime. Siemens sits at RSI 24.4, deeply oversold, with a DEGRADING industry tag. On the other side of the ledger, SAP printed +2.02% on the week and holds a 32% three-month move. TotalEnergies is up 61% on the year and pushing RSI 69. LVMH is down 19.6% over three months, broke both moving averages, and sits at RSI 27.5. Sanofi looks similar: RSI 28.7, below both MAs, with RBC just initiating at Sector Perform on "transition risks." The pattern across the tape: primes, semis and luxury are being sold; integrated energy and enterprise software are being bought.

Counter-thesis: the moves in ASML and Airbus are 4-week noise inside multi-quarter uptrends. Both still trade above their 200-day averages. The DEGRADING industry tag lags price by weeks and captures the last two months, not the next two quarters.

This would be wrong if ASML's next earnings print or an Airbus October order-book announcement snaps the tape back to trend. In that case DEGRADING is behind, not ahead.

Sources: France 24, Le Monde, TechTimes.

The catch ▸ Sanofi's tape agrees with the sell-side, not the pipeline story

On 9 September RBC initiated Sanofi at Sector Perform citing "transition risks." Nine days later Sanofi sits at RSI 28.7, below both its 200-day and 30-week moving averages, with -6.4% on the year. Separately Sanofi signed a next-generation vaccine manufacturing declaration with VNVC in Vietnam and pushed an EPO patent (HRP20260858T1) on ADAMTS5/MMP13/aggrecan-binding polypeptides — the pipeline noise is positive. The tape and the analyst are aligned against the pipeline. When price, oversold RSI and an initiation at Sector Perform all line up on the bearish side while headline flow reads constructive, the market is usually pricing something the headlines have not caught up to. Worth watching the next earnings print for what the analyst thinks he sees.

§03 · Companies of interest

Research surface — not investment advice.

Technicals: market data, computed 2026-09-18T05:08 UTC.

§04 · Calendar ahead

• 2026-09-23 · Riksbank rate decision (SE)
• 2026-09-24 · Norges Bank rate decision (NO)
• 2026-10-02 · US Non-Farm Payrolls

§05 · Disclaimer

This is research material, not investment advice.

Aavistus · 2026-09-18 · v0